Mersana Therapeutics Inc. appointed David Spellman to the position of CFO.
Most recently, Spellman served as vice president of corporate, commercial and international finance at Vertex Pharmaceuticals Inc.
Mersana Therapeutics appoints CFO
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Mersana Therapeutics Inc. appointed David Spellman to the position of CFO.
Most recently, Spellman served as vice president of corporate, commercial and international finance at Vertex Pharmaceuticals Inc.